Evolus Investor Presentation March 2022

Evolus presents its business strategy and financial outlook centered on Jeuveau®, a botulinum toxin product for aesthetic medicine. The presentation discusses market growth opportunities, product adoption, Phase II clinical trial plans for an extra-strength formulation, and competitive positioning in the dermatology market.